Kyowa Kirin Services Ltd

Tweet this page
<
2020
2021
2022
>
No longer registered as of 29 Mar 2023 - Registration as it was on 13 May 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

25,000€ - 49,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

0.35 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Kyowa Kirin Services Ltd

    EU Transparency Register

    352633837416-51 First registered on 21 Feb 2020

    Goals / Remit

    Kyowa Kirin commits to innovative drug discovery driven by state-of-the-art technologies. The company focuses on creating new values in the four therapeutic areas: nephrology, oncology, immunology/allergy and neurology. Under the Kyowa Kirin brand, the employees from 36 group companies across North America, EMEA and Asia/Oceania unite to champion the interests of patients and their caregivers in discovering solutions wherever there are unmet medical needs.

    Main EU files targeted

    European Reference Networks
    Orphan medicinal products
    Pharmaceutical policy
    Public health
    Rare diseases

    Address

    Head Office
    Kyowa Kirin Galabank Business Park
    Galashiels TD1 1QH
    UNITED KINGDOM
    EU Office
    2 Globeside Fieldhouse Lane
    Marlow SL7 1HZ
    UNITED KINGDOM

    Website

    http://www.kyowakirin.com

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%1
    10%1

    Lobbyists (Full time equivalent)

    0.35

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    IFPMA (International Federation of Pharmaceutical Manufacturers and Associations)
    EMIG (Ethical Medicines Industry Group)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    25,000€ - 49,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    fti 25,000€ - 49,999€

    Intermediaries for current year

    None declared

    Closed year Costs

    25,000€ - 49,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard